Where does Arog Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Arog Pharmaceuticals, Inc. ranks #11,550 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Arog Pharmaceuticals, Inc. hold?

Arog Pharmaceuticals, Inc. holds 26 US utility patents granted between 2015 and 2025, spanning 10 technology areas.

What is Arog Pharmaceuticals, Inc.'s Innovation Score?

Arog Pharmaceuticals, Inc. has an Innovation Score of 48.3 out of 100 (top 17% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Arog Pharmaceuticals, Inc. focus on?

Arog Pharmaceuticals, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 25 patents, ranking #906 of 7,163 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Arog Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Arog Pharmaceuticals, Inc.'s recent grant velocity is +56% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Arog Pharmaceuticals, Inc.'s patents?

Arog Pharmaceuticals, Inc.'s patents average 24.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Arog Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Arog Pharmaceuticals, Inc.

USPTO PatentsView assignee record - 26 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Arog ranks #11,550 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 10 technology areas.

#11,550
of 49,997 US assignees by volume: Top 17%
by Innovation Score (48.3/100): 24.4
avg claims per patent: +56%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11550 · US Corporation #11,550 · 26 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 26 grants
UPPER-Q #11,550/49,997
PHOTO-FINISH Ariat International
CPC-FOCUS A61K · 10 areas
INNOV-PAR 48.3/100
CLAIMS-DENSE 24.4 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +56% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ariat International, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Arog’s 48.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.4 pts (24%) Velocity 11.1 pts (23%) Breadth 11.2 pts (23%) Claim depth 14.7 pts (30%)

Qualcomm Incorporated · highest

85
Arog Pharmaceuticals · this assignee

48
Calmer Holding · near

48
Sight Sciences · near

48
Encite · near

48
Pegavision · near

48
3D Lighting… · lowest

7

What this shows Arog's Innovation Score is 48.3/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Arog?

Each dot is one of Arog’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Arog’s own 24.4 claims/patent is ABOVE the 17.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Arog vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Arog's grants concentrate

Arog Pharmaceuticals, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 96.2% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2023 (4 grants) versus a trough of 1 in 2018. By volume, Arog sits between Ariat International, Inc. and Axure Software Solutions, Inc..

Arog's three-year grant acceleration

Arog Pharmaceuticals, Inc. shows 10 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ariat Internation…

26
Arisdyne Systems

26
Arizona Board of…

26
Armis Security

26
Ashley Diana Blac…

26
Astrapi

26
Axsun

26
Axure Software So…

26
Arog Pharmaceutic… ◀

26

What this shows Arog holds 26 patents at rank #11,560, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Arog

By rank, the assignees closest to #11,560 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Arog's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Arog, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Arog ranks #906 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (48 here).

Calmer Holding Company, LLC 48 Sight Sciences, Inc. 48 Pegavision Corporation 48 Encite LLC 48

Arog's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 17% higher than 83% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Arog Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	7.7%
2016	2	7.7%
2017	2	7.7%
2018	1	3.8%
2019	2	7.7%
2020	2	7.7%
2021	2	7.7%
2022	3	11.5%
2023	4	15.4%
2024	3	11.5%
2025partial year	3	11.5%

Which technologies does Arog Pharmaceuticals, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 25

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 20

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 13

C12Y - Enzymes 7

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 4

C07K - Peptides 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

C07D - Heterocyclic Compounds 1

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Arog Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Arog Pharmaceuticals, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 96.2% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #11,550 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Arog Pharmaceuticals, Inc. against Ariat International, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.